These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29577623)

  • 1. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
    Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
    J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
    Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
    PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
    Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV incidence and impact of interventions among female sex workers and their clients in the Middle East and north Africa: a modelling study.
    Chemaitelly H; Ayoub HH; Omori R; El Feki S; Hermez JG; Weiss HA; Abu-Raddad LJ
    Lancet HIV; 2022 Jul; 9(7):e496-e505. PubMed ID: 35777411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.
    Mahmud S; Mumtaz GR; Chemaitelly H; Al Kanaani Z; Kouyoumjian SP; Hermez JG; Abu-Raddad LJ
    Addiction; 2020 Jul; 115(7):1244-1262. PubMed ID: 32009283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study.
    Ganapathi L; McFall AM; Srikrishnan AK; Kumar MS; Anand S; Lucas GM; Mehta SH; Harris SK; Solomon SS
    J Int AIDS Soc; 2019 May; 22(5):e25287. PubMed ID: 31116005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.
    Heijnen M; Mumtaz GR; Abu-Raddad LJ
    J Int AIDS Soc; 2016; 19(1):20873. PubMed ID: 27237131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
    Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
    AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.
    Escudero DJ; Lurie MN; Mayer KH; King M; Galea S; Friedman SR; Marshall BDL
    BMC Public Health; 2017 Jul; 17(1):614. PubMed ID: 28738861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
    Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
    Aaraj E; Jreij Abou Chrouch M
    Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.
    Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N;
    Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
    Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
    J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Evolving HIV Epidemic in the Middle East and North Africa (MENA) Region: A Scoping Review.
    Karbasi A; Fordjuoh J; Abbas M; Iloegbu C; Patena J; Adenikinju D; Vieira D; Gyamfi J; Peprah E
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
    Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
    J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
    Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
    Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan.
    Capelastegui F; Trickey A; Thompson LH; Reza T; Emmanuel F; Cholette F; Blanchard JF; Archibald C; Vickerman P; Lim AG
    Pathog Glob Health; 2023 Dec; 117(8):696-707. PubMed ID: 36950726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.
    Doyle CM; Cox J; Milwid RM; Bitera R; Delaunay CL; Alary M; Lambert G; Tremblay C; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2022 Sep; 25(9):e25994. PubMed ID: 36050916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.